Researchers have discovered that traumatic brain injuries (TBI) may increase the risk of developing Alzheimer’s disease. By ...

Repocitinib saw attention at the AAO for its first-in-class novel dual inhibitor mechanism of action in NIU field.

The study will evaluate the company’s Gen-3 Halo headset as an at-home treatment for mild traumatic brain injury.

Nexalin Technology (NXL) announced plans to commence a new clinical trial in collaboration with the University of California, San Diego. Dr ...

Gen-3 Halo Headset Designed to Offer Convenient At-Home Treatment Through Virtual Clinic Model Study to Build on Positive Results from Previous ...

Birmingham scientists have shown light therapy delivered transcranially (though the skull) can aid tissue repair after mild ...